RAIA DROGASIL SA
Location
SAO PAULO
Founded
1935-03-28
Website
Risk Signals
714 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Drug Stores and Proprietary Stores), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about RAIA DROGASIL SA
Live alerts from global media, monitored by Business Radar
2025-04-23 (acionista.com.br)
RD (Radl3) approves R $ 104 million in additional dividends - see how to have the right
RD-Raia Drogasil (RADL3) announced last Tuesday (22), after the end of the trading session, the approval of the distribution of additional dividends in the total amount of R $ 104 million, equivalent to R $ 0.060712182 per share. The decision was made during the Company's ordinary general meeting. According to a statement, the payment will be made to […]
Read more
2025-02-26 (riotimesonline.com)
RD Saúde Posts 34.6% Profit Growth in Q4 2024 -
RD Saúde, formerly Raia Drogasil (RADL3), reported a 34.6% increase in adjusted net income for the fourth quarter of 2024
Read more
2024-11-07 (oespecialista.com.br)
Raia Drogasil and Blau increase revenue in the quarter
Raia Drogasil reports revenue of R$10.8 billion, up 16% year-on-year; Blau Farmacêutica has revenue of R$474 million, an increase of 31%
Read more
2024-10-18 (oespecialista.com.br)
Pharmacies expected to grow above 10% in the third quarter
Preview of pharmaceutical retail results prepared analyzes the sector's favorable moment and cites the Pague Menos network as a positive highlight
Read more
2024-08-06 (inteligenciafinanceira.com.br)
With tax changes, RD Saúde's profit falls 3.4% and reaches R$ 326.6 million in the 2nd quarter
Ex-Raia Drogasil justifies the drop in profit compared to the same period in 2023 with changes in IR and CSLL taxation, in addition to lower JCP provision and the impact of non-recurring adjustments
Read more
2024-07-23 (noticiasaominuto.com.br)
Wegovy arrives at Brazilian pharmacies with prices starting at R$1,228
The previous forecast was that the products would only be available from August this year
Read more
2024-07-22 (paraibaonline.com.br)
Weight loss medicine arrives in Brazilian pharmacies; the price is 'fat'
Weight loss medicine arrives in Brazilian pharmacies; the price is 'fat'
Read more
2024-07-17 (acionista.com.br)
Recovering retail leaves the market optimistic
For some time now, perhaps pre-pandemic, there was no latent optimism in the retail sector, one of the most impacted by Covid-19. Shoo, go there!
Read more
2024-06-09 (acionista.com.br)
Raia Drogasil (RADL3) is not popular, but analysts see potential
The results of Raia Drogasil (RADL3) gave the market a headache, as the results for the second half were below consensus.
Read more